Enveric Biosciences, Inc. (ENVB) financial statements and ratios from SEC XBRL: revenue $39.91M (TTM), net margin -14.0%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $39.91M |
| Net Margin | -14.0% |
| Price / Book | 0.79 |
| Sector P/E (Healthcare) | 21.7 |
ENVB overview · ENVB earnings · ENVB KPIs · ENVB investor relations · ENVB ownership · ENVB peers · ENVB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.